BTG3 and breast cancer: Particularly, the presence of specific antibodies commonly found in SSc patients, such as antinuclear antibodies (ANA), anti-topoisomerase antibodies (ATA), and anticentromere antibodies (ACA), has been associated with an increased risk of cancer, including BC [1].